[1] Lindsberg PJ, Soinne L, Roine RO, Tatlisumak T. Options for recanalization therapy in basilar artery occlusion[J]. Stroke, 2005, 36:203-204.
[2] Qureshi AI, Ziai WC, Yahia AM, Mohammad Y, Sen S, Agarwal P, Zaidat OO, Suarez JI, Wityk RJ. Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis:a multicenter study[J]. Neurosurgery, 2003, 52:1033-1039.
[3] The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis[J]. Stroke, 1998, 29:1389-1392.
[4] Schonewille WJ, Wijman CA, Michel P, Rueckert CM, Weimar C, Mattle HP, Engelter ST, Tanne D, Muir KW, Molina CA, Thijs V, Audebert H, Pfefferkorn T, Szabo K, Lindsberg PJ, de Freitas G, Kappelle LJ, Algra A; BASICS study group. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS):a prospective registry study[J]. Lancet Neurol, 2009, 8:724-730.
[5] Liu L, Xu XT, Ma N, Gao F, Mo DP, Sun X, Song LG, Miao ZR. The treatment of collateral compensation and endovascular revascularization for symptomatic intracranial vertebrobasilar artery occlusion[J]. Zhonghua Shen Jing Wai Ke Za Zhi, 2017, 33:334-338[.刘恋, 徐晓彤, 马宁, 高峰, 莫大鹏, 孙瑄, 宋立刚, 缪中荣. 症状性颅内椎-基底动脉闭塞的侧支代偿及介入开通治疗[J]. 中华神经外科杂志, 2017, 33:334-338.]
[6] Markus HS, van der Worp HB, Rothwell PM. Posterior circulation ischaemic stroke and transient ischaemic attack:diagnosis, investigation, and secondary prevention[J]. Lancet Neurol, 2013, 12:989-998.
[7] Caplan LR, Wityk RJ, Glass TA, Tapia J, Pazdera L, Chang HM, Teal P, Dashe JF, Chaves CJ, Breen JC, Vemmos K, Amarenco P, Tettenborn B, Leary M, Estol C, Dewitt LD, Pessin MS. New England medical center posterior circulation registry[J]. Ann Neurol, 2004, 56:389-398.
[8] Müller-Küppers M, Graf KJ, Pessin MS, DeWitt LD, Caplan LR. Intracranial vertebral artery disease in the New England medical center posterior circulation registry[J]. Eur Neurol, 1997, 37:146-156.
[9] Voetsc B, Dewitt LD, Pessin MS, Caplan LR. Basilar artery occlusive disease in the New England medical center posterior circulation registry[J]. Arch Neurol, 2004, 61:496-504.
[10] Kubik CS, Adams RD. Occlusion of the basilar artery; a clinical and pathological study[J]. Brain, 1946, 69:73-121.
[11] Gulli G, Marquardt L, Rothwell PM, Markus HS. Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis:pooled data analysis from prospective studies[J]. Stroke, 2013, 44:598-604.
[12] Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Prider GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS):the final results of a randomised trial[J]. Lancet, 2014, 383:333-341.
[13] Moufarrij NA, Little JR, Furlan AJ, Leatherman JR, Williams GW. Basilar and distal vertebral artery stenosis:long-term follow-up[J]. Stroke, 1986, 17:938-942.
[14] Abuzinadah AR, Alanazy MH, Almekhlafi MA, Duan Y, Zhu H, Mazighi M, Lutsep HL, Donnon T, Hill MD. Stroke recurrence rates among patients with symptomatic intracranial vertebrobasilar stenoses:systematic review and meta-analysis[J]. J Neurointerv Surg, 2016, 8:112-116.
[15] Lindsberg PJ, Soinne L, Tatlisumak T, Roine RO, Kallela M, Häppölä O, Kaste M. Long-term outcome after intravenous thrombolysis of basilar artery occlusion[J]. JAMA, 2004, 292:1862-1866.
[16] Dashti SR, Park MS, Stiefel MF, McDougall CG, Albuquerque FC. Endovascular recanalization of the subacute to chronically occluded basilar artery:initial experience and technical considerations[J]. Neurosurgery, 2010, 66:825-831.
[17] Edgell RC, Yavagal DR, Drazin D, Olivera R, Boulos AS. Treatment of vertebral artery origin stenosis with anti-proliferative drug-eluting stents[J]. J Neuroimaging, 2010, 20:175-179.
[18] Taylor RA, Siddiq F, Suri MF, Martin CO, Hayakawa M, Chaloupka JC. Risk factors for in-stent restenosis after vertebral ostium stenting[J]. J Endovasc Ther, 2008, 15:203-212.
[19] Edgell RC, Zaidat OO, Gupta R, Abou-Chebl A, Linfante I, Xavier A, Nogueira R, Alshekhlee A, Kalia J, Etezadi V, Aghaebrahim N, Jovin T. Multicenter study of safety in stenting for symptomatic vertebral artery origin stenosis:results from the Society of Vascular and Interventional Neurology Research Consortium[J]. J Neuroimaging, 2013, 23:170-174.
[20] Ausman JI, Lee MC, Klassen AC, Seljeskog EL, Chou SN. Stroke:what's new? Cerebral revascularization[J]. Minn Med, 1976, 59:223-227. |